A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice
Keywords: Dengue; Vaccine; Domain III; Capsid; Adjuvant; P64k;